SEATTLE GENETICS INC Collaboration Agreements
19 Contracts & Agreements
- Collaboration and License Agreement dated January 7, 2007 between (Filed With SEC on February 9, 2022)
- License and Collaboration Agreement relating to ladiratuzumab vedotin dated September 13, 2020 between Seagen Inc. (f/k/a Seattle Genetics, Inc.) and Merck Sharp & Dohme Corp (Filed With SEC on October 30, 2020)
- Collaboration Agreement between Seattle Genetics, Inc. and Millennium Pharmaceuticals, Inc. (a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited) dated December 14,... (Filed With SEC on February 6, 2020)
- License and Collaboration Agreement, effective October 7, 2011, between Genmab A/S and Seattle Genetics, Inc (Filed With SEC on November 6, 2017)
- AMENDMENT TO COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on March 12, 2010)
- COLLABORATION AGREEMENT (Filed With SEC on November 7, 2008)
- COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on May 8, 2007)
- COLLABORATION AGREEMENT (Filed With SEC on May 8, 2007)
- COLLABORATION AGREEMENT (Filed With SEC on August 9, 2005)
- COLLABORATION AGREEMENT (Filed With SEC on August 9, 2005)
- COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on November 10, 2004)
- COLLABORATION AGREEMENT by and between SEATTLE GENETICS, INC. (Filed With SEC on November 10, 2004)
- AMENDMENT NO. 2 TO COLLABORATION AGREEMENT (Filed With SEC on November 10, 2004)
- COLLABORATION AGREEMENT (Filed With SEC on August 10, 2004)
- AMENDMENT TO COLLABORATION AGREEMENT BY AND BETWEEN SEATTLE GENETICS, INC. AND PROTEIN DESIGN LABS, INC. (Filed With SEC on May 10, 2004)
- AMENDMENT NO. 1 TO COLLABORATION AGREEMENT (Filed With SEC on November 12, 2003)
- COLLABORATION AGREEMENT (Filed With SEC on May 14, 2002)
- COLLABORATION AGREEMENT (Filed With SEC on May 14, 2002)
- COLLABORATION AGREEMENT (Filed With SEC on August 13, 2001)
